Meridian Financial Partners’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$327K Buy
1,585
+3
+0.2% +$665 0.12% 90
2025
Q4
$342K Buy
1,582
+9
+0.6% +$2.05K 0.14% 87
2025
Q3
$364K Buy
1,573
+9
+0.6% +$1.83K 0.15% 83
2025
Q2
$290K Buy
1,564
+1
+0.1% +$186 0.14% 89
2025
Q1
$327K Sell
1,563
-160
-9% -$31.1K 0.17% 83
2024
Q4
$306K Hold
1,723
0.16% 80
2024
Q3
$340K Sell
1,723
-36
-2% -$6.72K 0.17% 79
2024
Q2
$301K Hold
1,759
0.18% 69
2024
Q1
$286K Buy
1,759
+40
+2% +$6.89K 0.37% 34
2023
Q4
$281K Buy
+1,719
New +$251K 0.29% 43
2023
Q2
Sell
-1,325
Closed -$211K 87
2023
Q1
$211K Sell
1,325
-4,330
-77% -$662K 0.24% 44
2022
Q4
$841K Sell
5,655
-6
-0.1% -$920 0.95% 27
2022
Q3
$809K Buy
5,661
+389
+7% +$55.8K 1.15% 23
2022
Q2
$797K Buy
5,272
+151
+3% +$23.1K 0.54% 47
2022
Q1
$830K Buy
5,121
+76
+2% +$11K 1.24% 23
2021
Q4
$682K Buy
+5,045
New +$596K 0.46% 46

Other funds holding ABBV